Track the 지노믹트리 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 지노믹트리 has published 27 reports. The latest transaction was filed on 22 May 2026 (Purchase). Among the most active insiders: 이홍선. The full history is free.
27
Insider Decl.
n/a
Thresholds
n/a
19 ops.
Buy Volume
n/a
6 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Genomictree es líder en pruebas genéticas en Corea del Sur, proporcionando soluciones innovadoras para el diagnóstico y tratamiento de enfermedades. La empresa cotiza en el mercado XKRX.